The role of FOXM1 and PD-L1 in malignant peripheral nerve sheath tumor resistance

A new mini review was published in Oncotarget’s Volume 15 on September 30, 2024, entitled, “Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors.”

Can Childhood Trauma Prime Brain Dynamics for Nicotine Dependence?

Childhood trauma-related emotion dysregulation may partly explain why some long-term smokers are unable to give up nicotine, a cross-sectional study suggested. Using 16-minute resting-state functional

January 13, 2024

Understanding deprivation measures: A key to equitable public health resource allocation

Over the course of the pandemic, COVID-19 hit Black communities and communities of color particularly hard.

December 7, 2023

Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results – Medical Marijuana, Inc.

SAN DIEGO, CA, Aug. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United

May 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.